Proven Neonatal Neuroprotection Strategies
Clinics in Perinatology · 2026-09 · 53 (3) · 601-616
DOI: 10.1016/j.clp.2026.04.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Perinatology, 2026-09. Verfasst von Helene B Bernstein. Beteiligte Einrichtung: Upstate Medical University, College of Medicine, Syracuse, NY 13205, USA. Electronic address: Heleneb825@gmail.com. Hauptthemen laut MEDLINE: Magnesium Sulfate, Hypothermia, Induced, Hypoxia-Ischemia, Brain, Neuroprotective Agents. Die Arbeit nennt 59 Literaturangaben.
Abstract (Originalsprache)
Neurodevelopmental impairments follow both term and preterm birth, and include cerebral palsy (CP), cognitive dysfunction, and sensory impairment (blindness and deafness). Proven neuroprotective strategies include antepartum magnesium sulfate (MgSO4) administration prior to anticipated preterm delivery, delayed cord clamping, and therapeutic hypothermia for term and late preterm infants. MgSO4 administration prior to anticipated preterm delivery has been shown to reduce the risk of death, cerebral palsy and major neurodevelopmental disorders, whereas therapeutic hypothermia in term and later preterm infants has been shown to prevent or reduce sequelae associated with hypoxic-ischemic encephalopathy (HIE).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Upstate Medical University, College of Medicine, Syracuse, NY 13205, USA. Electronic address: Heleneb825@gmail.com.
Zitieren
APA
Bernstein, H. B. (2026). Proven Neonatal Neuroprotection Strategies. Clinics in Perinatology, 53(3), 601-616. https://doi.org/10.1016/j.clp.2026.04.003
Vancouver
Bernstein HB. Proven Neonatal Neuroprotection Strategies. Clinics in Perinatology. 2026;53(3):601-616. doi:10.1016/j.clp.2026.04.003
BibTeX
@article{Bernstein2026,
author = {Bernstein, Helene B},
title = {Proven Neonatal Neuroprotection Strategies},
journal = {Clinics in Perinatology},
year = {2026},
volume = {53},
number = {3},
pages = {601--616},
doi = {10.1016/j.clp.2026.04.003}
}
EUVIMED